BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liang X, Zhang Z, Wang L, Zhang S, Ren L, Li S, Xu J, Lv S. Mechanism of methyltransferase like 3 in epithelial-mesenchymal transition process, invasion, and metastasis in esophageal cancer. Bioengineered 2021;12:10023-36. [PMID: 34666602 DOI: 10.1080/21655979.2021.1994721] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Teng C, Kong F, Mo J, Lin W, Jin C, Wang K, Wang Y. The roles of RNA N6-methyladenosine in esophageal cancer. Heliyon 2022. [DOI: 10.1016/j.heliyon.2022.e11430] [Reference Citation Analysis]
2 Li Y, Niu C, Wang N, Huang X, Cao S, Cui S, Chen T, Huo X, Zhou R. The Role of m6A Modification and m6A Regulators in Esophageal Cancer. Cancers 2022;14:5139. [DOI: 10.3390/cancers14205139] [Reference Citation Analysis]
3 Li W, Hao Y, Zhang X, Xu S, Pang D. Targeting RNA N6-methyladenosine modification: a precise weapon in overcoming tumor immune escape. Mol Cancer 2022;21:176. [PMID: 36071523 DOI: 10.1186/s12943-022-01652-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Huang J, Wang Y, Zha Y, Zeng X, Li W, Zhou M. Transcriptome Analysis Reveals Hub Genes Regulating Autophagy in Patients With Severe COVID-19. Front Genet 2022;13:908826. [DOI: 10.3389/fgene.2022.908826] [Reference Citation Analysis]
5 Xia Z, Kong F, Wang K, Zhang X. Role of N6-Methyladenosine Methylation Regulators in the Drug Therapy of Digestive System Tumours. Front Pharmacol 2022;13:908079. [PMID: 35754499 DOI: 10.3389/fphar.2022.908079] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Liu J, Tang G, Liu W, Zhou Y, Fan C, Zhang W. MiR-20a-5p facilitates cartilage repair in osteoarthritis via suppressing mitogen-activated protein kinase kinase kinase 2. Bioengineered 2022;13:13801-14. [PMID: 35707845 DOI: 10.1080/21655979.2022.2084270] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Xue C, Chu Q, Zheng Q, Jiang S, Bao Z, Su Y, Lu J, Li L. Role of main RNA modifications in cancer: N6-methyladenosine, 5-methylcytosine, and pseudouridine. Signal Transduct Target Ther 2022;7:142. [PMID: 35484099 DOI: 10.1038/s41392-022-01003-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
8 Peng K, Chen X, Lin A, Tong Z, Lin W. PolyC-RNA-binding protein 1 (PCBP1) enhances tropomyosin 3 (TPM3) mRNA stability to promote the progression of esophageal squamous cell carcinoma. Bioengineered 2022. [PMID: 35287546 DOI: 10.1080/21655979.2022.2053801] [Reference Citation Analysis]
9 Wei K, Gao Y, Wang B, Qu YX. Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7). Bioengineered 2022;13:5236-50. [PMID: 35156522 DOI: 10.1080/21655979.2022.2037381] [Reference Citation Analysis]
10 Wang F, Xie Z, Zhang N, Ding H, Xiong K, Guo L, Huang H, Wen Z. Has_circ_0008583 modulates hepatocellular carcinoma progression through the miR-1301-3p/METTL3 pathway. Bioengineered 2022;13:1185-97. [DOI: 10.1080/21655979.2021.2017579] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]